Natus Medical Inc: Silvercrest Asset Management Group Llc Disclosed Stake

February 14, 2018 - By Dolores Ford

 Natus Medical Inc: Silvercrest Asset Management Group Llc Disclosed Stake

Investors sentiment decreased to 0.76 in Q3 2017. Its down 0.41, from 1.17 in 2017Q2. It dropped, as 32 investors sold Natus Medical Incorporated shares while 70 reduced holdings. 20 funds opened positions while 58 raised stakes. 30.60 million shares or 0.12% more from 30.57 million shares in 2017Q2 were reported.

Martingale Asset Ltd Partnership stated it has 0.01% in Natus Medical Incorporated (NASDAQ:BABY). Jefferies Grp Inc Lc holds 0% of its portfolio in Natus Medical Incorporated (NASDAQ:BABY) for 13,723 shares. Manufacturers Life Insur Communication The owns 0% invested in Natus Medical Incorporated (NASDAQ:BABY) for 24,660 shares. Gp Incorporated accumulated 25,767 shares. Clarivest Asset Mngmt Lc, California-based fund reported 60,725 shares. Benjamin F Edwards & Company stated it has 2,732 shares. Utd Service Automobile Association reported 116,105 shares. 319,481 are owned by Nationwide Fund Advsrs. Jpmorgan Chase And holds 37,767 shares or 0% of its portfolio. Virginia Retirement System Et Al invested in 36,200 shares. Teachers Retirement Systems Of The State Of Kentucky has 62,094 shares. Principal Fincl Grp owns 250,798 shares. Moreover, Aperio Grp Limited Liability Corporation has 0% invested in Natus Medical Incorporated (NASDAQ:BABY) for 5,904 shares. Pub Sector Pension Invest Board holds 0% or 20,810 shares in its portfolio. Hanson Mcclain invested in 5,789 shares.

Since August 14, 2017, it had 0 insider buys, and 1 insider sale for $154,748 activity. MOORE WILLIAM M sold $102,300 worth of stock.

The New Silvercrest Asset Management Group Llc Holding in Natus Medical Inc

Silvercrest Asset Management Group Llc reported SC 13G form with the SEC for Natus Medical Inc. Access it here: 000119312518044321. As reported by Silvercrest Asset Management Group Llc, the filler owns 5.1% or 1,587,355 shares of the Health Care–company.

Natus Medical Inc stake is new for [reportingPerson]. Date of activity: December31, 2017. This shows Silvercrest Asset Management Group Llc’s positive view for Natus Medical Inc. For a hedge fund managing $15.87 billion in assets and having 97+ experts this is interesting position.

The hedge fund is investor in the Health Care sector. In the manager’s last 13-F, we saw 12% of Silvercrest Asset Management Group Llc’s portfolio is in the sector.

Natus Medical Inc Institutional Sentiment

Filings show 183 investors own Natus Medical Inc. The ownership in Q3 2015 is high, at Infinity of the outstanding shares. This is increased by 1772432. 27304305 were owned by these investors. 20 funds opened new Natus Medical Inc stakes, 72 increased positions. There were 21 that closed positions and 73 reduced them.

5 investors had the stock in their top 10. Some are: Lyon Street Capital Llc, Pax World Management Llc..

Domini Social Investments Llc is an investor bullish on Natus Medical Inc, owning 7331 shares as of Q3 2015 for 4.72% of its portfolio. Ed Beddow And William Tichy Beddow Capital Management Inc owns 229995 shares or 3.80% of its portfolio. VA Motley Fool Asset Management Llc have 3.47% of its portfolio for 448741 shares. Further, Alphaone Investment Services Llc reported stake worth 2.05% of its portfolio. The CA Lyon Street Capital Llc owns 175068 shares. Natus Medical Inc is 5.01% of its portfolio.

Business Profile

Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The Company’s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn’s environment, and software systems for managing and tracking disorders and diseases for public health laboratories. The Company is organized into three strategic business units: Neurology, Newborn Care and Otometrics.

SEC Form 13G.

Silvercrest Asset Management Group Llc website.

The stock increased 0.33% or $0.1 during the last trading session, reaching $30.5. About 468,009 shares traded. Natus Medical Incorporated (NASDAQ:BABY) has risen 4.38% since February 14, 2017 and is uptrending. It has underperformed by 12.32% the S&P500.

Natus Medical Incorporated provides newborn care and neurology healthcare services and products worldwide. The company has market cap of $934.63 million. It offers services and products used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders. It currently has negative earnings. The company's product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories.

Natus Medical Incorporated (NASDAQ:BABY) Ratings Coverage

Among 5 analysts covering Natus Medical (NASDAQ:BABY), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. Natus Medical has $55 highest and $39 lowest target. $49.67’s average target is 62.85% above currents $30.5 stock price. Natus Medical had 10 analyst reports since July 23, 2015 according to SRatingsIntel. The rating was maintained by TH Capital with “Buy” on Thursday, July 23. Roth Capital maintained Natus Medical Incorporated (NASDAQ:BABY) on Monday, September 11 with “Buy” rating. The stock of Natus Medical Incorporated (NASDAQ:BABY) earned “Buy” rating by TH Capital on Thursday, October 22. Benchmark initiated Natus Medical Incorporated (NASDAQ:BABY) rating on Tuesday, October 4. Benchmark has “Buy” rating and $55 target. Raymond James upgraded the shares of BABY in report on Tuesday, September 13 to “Outperform” rating. The firm has “Buy” rating given on Friday, June 23 by Roth Capital. As per Thursday, February 2, the company rating was downgraded by Raymond James. The firm earned “Buy” rating on Tuesday, April 5 by Roth Capital. The firm has “Buy” rating by TH Capital given on Tuesday, January 12. The stock has “Hold” rating by William Blair on Monday, January 8.

More notable recent Natus Medical Incorporated (NASDAQ:BABY) news were published by: Fool.com which released: “Oh Baby! Natus Medical Inc. Beats and Raises Guidance” on October 26, 2017, also Fool.com with their article: “Why Natus Medical Inc Sank Lower Today” published on January 08, 2018, Fool.com published: “Why Natus Medical Inc. Sank Today” on April 26, 2017. More interesting news about Natus Medical Incorporated (NASDAQ:BABY) were released by: Fool.com and their article: “Natus Medical Inc Looks to Turn Things Around” published on July 27, 2017 as well as Fool.com‘s news article titled: “Natus Medical Inc: This BABY Has Some Growing Pains” with publication date: April 27, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.